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Abstract
The complex evolution of secondary metabolism is important in biology, drug development, and synthetic biology. To
examine this problem at a fine scale, we compared the genomes and chemistry of 24 strains of uncultivated cyanobacteria,
Prochloron didemni, that live symbiotically with tropical ascidians and that produce natural products isolated from the
animals. Although several animal species were obtained along a .5500 km transect of the Pacific Ocean, P. didemni strains
are .97% identical across much of their genomes, with only a few exceptions concentrated in secondary metabolism.
Secondary metabolic gene clusters were sporadically present or absent in identical genomic locations with no consistent
pattern of co-occurrence. Discrete mutations were observed, leading to new chemicals that we isolated from animals.
Functional cassettes encoding diverse chemicals are exchanged among a single population of symbiotic P. didemni that
spans the tropical Pacific, providing the host animals with a varying arsenal of secondary metabolites.
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Introduction
Marine invertebrates such as sponges, ascidians, and mollusks
are sources of abundant and diverse secondary metabolites, many
of which are drugs or drug leads [1,2]. The metabolites impact
marine environments, and many have defined biological roles, for
example helping animals to evade predation on coral reefs [3]. A
major unanswered question has been what controls the distribu-
tion and synthesis of these animal compounds across the oceans.
Marine invertebrate natural products are often very sporadic in
their occurrence, and chemistry varies between seemingly identical
samples, even from animals living next to each other [4]. It has
been shown that a number of marine invertebrate natural
products are actually synthesized by symbiotic bacteria [5,6,7],
which is especially striking because some of these ‘‘bacterial’’
molecules may be critical for survival of hosts.
Secondary metabolism represents one of the most common and
varied features of bacterial genomes [8,9]. Animals harness this
diverse bacterial metabolism for their survival, and it is increasingly
apparent that this is a widespread phenomenon on both land and
sea [10]. For example, in wasps a symbiotic bacterial species
synthesizes a mini-library of antibiotic secondary metabolites to
protect the animal larvae from bacterial infection [11]. However,
very little is known about how animals obtain these defenses or
about what controls variation in defensive chemicals found in
animals. In cultivated bacteria, even in closely related strains
chemistry is quite variable, but these strains have been removed
from their environment, so that no immediate environmental
relevance can be discerned. In addition, in cultivated bacteria there
areusuallymany mutationsbetweenstrains, so that precisegenomic
changes underlying chemical variation cannot be readily deter-
mined. By contrast, symbiosis affords an opportunity to examine
immediately the effects of genomic changes in the realenvironment,
and very precise genomic changes can be identified [10].
For example, about 1000 natural products have been isolated
from marine ascidian animals, including more than 60 cyclic
peptides of the cyanobactin class that form large families of related
compounds [12]. These potently cytotoxic compounds are often
abundant components of the biomass, to the point that they are
the major constituents of whole animal extracts. In addition, some
species of ascidians house uncultivated cyanobacterial symbionts,
Prochloron didemni, which form near monocultures in whole animals
that can be readily observed by eye because of the resulting bright
green color of the hosts (Figure 1) [13]. P. didemni is important to
both the primary and secondary metabolism of host ascidians, and
in some cases it has been shown to be essential for ascidian
survival. P. didemni transfers fixed carbon and recycles nitrogen
waste for the host ascidians, allowing the animals to survive in low-
nutrient, high-light intensity environments [14]. We previously
demonstrated that P. didemni synthesizes cyanobactin secondary
metabolites isolated from whole ascidians and that bacterial strain
variation underlies the varied ‘‘ascidian’’ natural products
(Figure 1) [6,15,16,17].
The P. didemni-ascidian system thus afforded a natural
laboratory to study the precise genomic basis of symbiosis and
pathway variation in a native context. The symbiotic bacteria are
transmitted via an ascidian species-specific combination of
horizontal and vertical transmission, allowing the bacteria to
specialize within their ascidian hosts while potentially exchanging
genetic information between individuals and even between other
species in the ocean [18,19]. Ascidian colonies are able to divide
and fuse in just a few days [20], possibly facilitating such exchange.
PLoS ONE | www.plosone.org 1 March 2011 | Volume 6 | Issue 3 | e17897P. didemni inhabits many different species of ascidians that occupy
different habitats [13]. Here, we apply metagenomic sequencing
and chemical analysis to examine variation over whole genomes
across the tropical Pacific. Three samples containing P. didemni
were deeply sequenced, providing high-resolution data of the
genomic changes across the tropical Pacific and defining three
types of precise genomic changes that lead to libraries of natural
products in animal-bacteria associations. We show that the
observed strain variation is largely focused in sporadically
distributed secondary metabolic gene clusters, providing the
animal-bacterial assemblages with a variable arsenal of chemical
products in an otherwise conserved genomic background. An
additional 21 samples from diverse locations and habitats were
further examined by PCR, verifying these trends across a vast
swathe of the Pacific Ocean. Chemical analysis confirmed the
genomic observations, leading us to discover that adjacent,
identical colonies vary in their symbiotic and chemical content.
This observation provides a new paradigm for natural product
discovery and reveals a natural combinatorial laboratory for the
synthesis of diverse chemicals harnessed by the animal hosts.
Results
Metagenome sequencing
We obtained didemnid ascidians from different habitats across
the tropical Pacific, including Palau, Papua New Guinea, the
Solomon Islands, and Fiji. Three samples of the ascidian
Lissoclinum patella, collected on shallow outer-reef ledges, were
used for metagenome sequencing: P1 (Palau), P2 (Fiji), and P3
(Solomon Islands). An additional 21 samples of diverse species and
locations were further analyzed by a PCR-based approach.
Because P. didemni is resistant to cultivation and constitutes over
95% of the host-associated microbes in some cases, preserved
samples were examined using molecular methods. The metagen-
ome of P1 was analyzed by Sanger sequencing and 454
pyrosequencing supplemented with fosmid library end-sequencing
while P2 and P3 were analyzed using 454 pyrosequencing and
fosmid end-sequencing. These methods allowed the genome of P.
didemni P1 to be assembled into 39 scaffolds with 98 physical gaps,
with a total sequence length of ,6,035 kbp. P2 and P3 were
sequenced to ,90x and ,14x coverage (based on contigs $1 kbp)
and assembled with N50 sizes of 18.5 kbp and 7.7 kbp,
respectively, into smaller fragments that are readily mapped to
P1 (File S1).
Genome analysis and secondary metabolism
Detailed bioinformatics methods were used to ensure the source
and quality of the P. didemni sequence (see Materials and Methods).
To determine whether the three sequenced samples could be
composed of populations of multiple individual Prochloron strains
with genomic inter-strain variations we examined several genetic
loci in detail, including ribosomal RNA clusters, the Prochloron-
Figure 1. Secondary metabolic pathways from three Prochloron metagenomes. Center: Prochloron cells (top) from the ascidian L. patella
(bottom). Surrounding are ten pathway types identified, comprising 15 distinct biosynthetic gene clusters in the metagenomes of P1, P2 and P3.
Compounds that have been chemically isolated are indicated by an asterisk; the remainder are genome-based predictions.
doi:10.1371/journal.pone.0017897.g001
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metabolite gene clusters. These genetic loci were examined at the
read level and searched for genetic variation within the samples
and changes in the coverage compared to the genome average. In
all examined cases, we found no indication of multiple genomic
variants within any of the three samples, supporting that only one
major Prochloron genotype is present in each sample. The cao gene is
a housekeeping gene specific to P. didemni that is essential for
photosynthetic cofactor biosynthesis [21].
Complete draft genome sequences of all predicted contigs from P2
and P3 were largely identical to that of P1, with .97% DNA
sequence identity across ,90% of the P1 chromosome (Figure 2).
The remaining ,10% of these genomes is characterized by the
presence of numerous, highly variable paralogous genes (such as
multiplesimilarcopiesof ankyrinrepeat-containing genes)containing
multiple repetitive elements as well as a set of genes with no assigned
function.Amongthegenesforwhichfunctionscouldbecalled,nearly
all were involved in secondary metabolism (116 out of 126 assignable
differencesinpairwisecomparisons).Wealsoobservedthatindividual
sequence regions of interest appeared to be syntenic, leading us to
propose that the entire genomes were largely identical and syntenic,
with the exception of repeats, secondary metabolism genes, and a
small number of other genes. This synteny was confirmed by
numerous experimental methods defined in Materials and Methods.
We analyzed the secondary metabolic gene content of P1, P2,
and P3, searching for polyketide synthases, terpene synthases, and
ribosomal and nonribosomal peptide pathways. Representatives of
all four pathway types were identified in the genomes, leading to a
total of ten biosynthetic gene families in 15 distinct clusters
(Figure 1). A complete analysis of these clusters was performed,
enabling prediction of likely products in most cases (Materials and
Methods and File S1). Only three of these clusters are shared
between all three strains, while the remainder are found only in
one or two of the strains. In all cases where a cluster was found in
more than one strain, the genes are essentially identical (.99–
100% DNA sequence identity) and are present in conserved
locations on the chromosomes. The chromosomal location could
be assessed in the genome-sequenced strains and also for five
specific pathways that were examined across an additional 21
samples that were examined by PCR (see below). We identified
three trends, which to the best of our knowledge have not been
previously observed at high resolution (Figure 3): 1) presence or
absence of individual gene clusters in identical chromosomal
locations, leading to the presence or absence of whole groups of
natural products in ascidians; 2) crossovers within pathways
leading to new functionality within very similar natural product
types, all in identical chromosomal genetic backgrounds; and 3)
hypervariable changes in short (,30 base pair) cassettes whose
Figure 2. Variations in secondary metabolic gene clusters constitute the major difference between the P. didemni genomes. a) The
Artemis Comparison Tool (ACT) was used to visualize pair-wise comparisons between contig ASM-2318 from P1 and corresponding contigs from P2
and P3 [44]. Violet color indicates $ 96% nucleotide identity while light blue color indicates 90–96% nucleotide identity. Two of the three differing
regions marked by black boxes differ solely due to natural product gene clusters. This pattern is reproduced throughout the 3 metagenomes. b) and
c) Dot Plot representations of NUCmer comparisons showing synteny between the same genetic regions as in A [45].
doi:10.1371/journal.pone.0017897.g002
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identical DNA sequence environments.
Analysis of secondary metabolic gene clusters
Three nonribosomal peptide synthetase pathways were identi-
fied: nkd, pyr, and the previously reported prn [15]. nkd is predicted
to encode a new compound related to the nikkomycins, which are
normally associated with actinomycetes [22]. pyr is related to
halogenated pyrrole pathways [23], while the product of prn
cannot be accurately analyzed because of a noncanonical gene
architecture. nkd was found only in P3, although a residual
methyltransferase gene from the pathway was identified in P1 at
the same chromosomal location. pyr was found in P2 and P3, while
prn was found only in P1. Two polyketide synthase genes were
identified: one of these is potentially part of the prn cluster and is
found in P1 only, while the other, gaz, is found in all 3 strains. In
these strains, gaz is identical except for a variable copy number of a
small repeating sequence element. The gaz-encoded polyketide
synthase is very similar to the C-terminus of the last polyketide
synthase in the curacin cluster [24,25]. We predicted that this gene
should synthesize a terminal olefin hydrocarbon. Recently,
cyanobacterial hydrocarbon biosynthesis was defined, and this
type of pathway would widen bacterial hydrocarbon synthesis to
include terminal olefins [26],[27]. A terpene synthase gene cluster
that should lead to bacterial lanosterone biosynthesis is also
present in all three strains [28].
The nonribosomal, polyketide, and terpene genes are discretely
either present or absent in identical chromosomal locations in all
Figure 3. Schematic representation of the different levels of changes in functional cassettes in P. didemni genomes. Three levels can
be observed: 1. Presence or absence of a gene cluster in the genome. Homologous gene clusters are .99% identical between strains; 2. Swaps of
function (heterocyclization to prenylation) within otherwise .99% identical gene clusters; 3. Functional point mutations in gene clusters (for example
in product-coding sequences of ribosomal peptides).
doi:10.1371/journal.pone.0017897.g003
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sequences are essentially identical, although sometimes various
numbers of nearly identical repetitive elements flank the gene
clusters. The analysis of ribosomal peptide natural product
biosynthesis is relatively more complicated. Four types of
ribosomal peptide pathways were identified, with only one class
being present in all three strains. In addition, where classes overlap
between two strains, the genes encoding modifying enzymes are
essentially (.99%) identical, while small portions of the precursor
peptide genes are hypervariable, so that the actual natural
products differ between strains. Although the phenomenon of
bacterial precursor peptide variation is becoming more widely
appreciated [29,30,31], P. didemni provides the first case where
such precisely defined differences have been observed.
In ribosomal peptide pathways, a precusor peptide is modified
by enzymes to produce natural products, such as the well-known
lantibiotics and microcins [30,32], The precursor peptide contains
a leader sequence, which directs the peptide to enzymes and which
is often later removed by proteases, and a core sequence, which
encodes the mature natural product and which is the substrate for
enzyme modification. In the four P. didemni ribosomal pathways,
the core sequences are hypervariable, while the leader sequences
and all of the flanking genes are nearly 100% identical.
Two new ribosomal pathways were discovered in this analysis:
hyd and tom. While hyd is present in all three strains, tom is only
present in P1 and P2. hyd was predicted to synthesize natural
products similar to virenamides, which have been isolated from
Prochloron-bearing ascidians [33], while tom is a streptolysin S-like
cluster of the so-called TOMM group [29,34]. Although the
predicted modifying genes are identical when present and the
clusters occupy identical genetic regions, the core sequences are
hypervariable.
We previously reported an additional two classes of ribosomal
peptide pathways, but with this report new genome-scale
evolutionary analysis is available providing new insights into
pathway evolution. These two classes, pat and tru, lead to synthesis
of cyanobactin natural products, which are small, N-C macrocy-
clic peptides isolated from ascidians and free-living cyanobacteria,
among other organisms (Figure 1, lower left) [6,17]. pat leads to
compounds that are also heterocyclic at cysteine, serine, and
threonine. By contrast, tru products are heterocyclic only at
cysteine and instead are prenylated at serine and threonine. Both
product groups, which are potent cytotoxins, are abundantly
concentrated, at up to ,1% dry weight, in whole ascidians. As
previously reported, pat and tru are essentially identical in most of
the ,11 kbp operons, comprising the 59- and 39-regions of the
pathways. In the central ,4.5 kbp regions of the operons, all genes
are homologous, but their DNA sequence identity lies between
77% and 25%. This crossover region is solely responsible for
imparting the change in prenylation and oxidation states, as
demonstrated previously by pathway expression in E. coli
[6,16,17].
pat is only present in P1. However, there are 2 nearly identical
copies of pat that are distantly located on the P1 chromosome. In
pat1, a precursor peptide encodes the synthesis of the ‘‘ascidian’’
natural products patellamides C and A. In pat2, the precursor
peptide encodes the products patellamides C and ulithiacycliamide
(in place of patellamide A). These entire ,11 kbp pathways have
identical DNA-sequences except for the 24-base pair cassettes
encoding patellamide A or ulithiacyclamide, which are only 46%
identical [16].
tru is present in both P2 and P3 in a single copy, in the same
location as the pat2 pathway in P1 (Figure 3). The flanking regions
are identical to pat, as noted above, and only the central
prenylating/oxidizing region differs between pat and tru. From
whole-genome sequencing, it is apparent that the ,11 kbp tru
clusters from P2 and P3 are also essentially identical, with two
exceptions. Like pat, they encode different natural products in
hypervariable core sequences, including the anticancer lead
compound, trunkamide [17]. Unlike pat, where the clusters are
identical along their lengths, the two tru pathways have
recombined with pat at least twice, leaving scars in slightly
different locations. In P2 and P3, the integration site of the tru-
specific region differs by several base pairs in the 59-region, and by
nearly 300 base pairs in the 39-region. This is striking given that
the samples were obtained .1000 km apart in the ocean and can
only be reasonably explained by at least two separate recombi-
nation events.
Sporadic variation of secondary metabolism
Based on comparisons of predicted P. didemni contigs, P2 and P3
seem to be phylogenetically slightly more related to each other
(98% identity) than to P1 (97% identity). Nonetheless, the
secondary metabolic pathways vary just as much between P2
and P3 as they do between either strain and P1. Therefore, it
seemed that the variation in pathways between these strains could
be largely a result of gene loss from an ancestral strain containing
all of the pathways, or alternatively horizontal transfer from non-
Prochloron strains could account for the differences. To test these
hypotheses, 21 additional samples from a .5500 km transect of
the Pacific were analyzed chemically and by PCR targeting the
integration loci for the presence/absence of biosynthetic genes
(File S1). These samples included the microbial content of
taxonomically diverse ascidian species and multiple replicates of
L. patella, which were collected at different times (2002, 2003,
2005, 2006, and 2007) and over an extensive transect. Because the
exact site of pathway insertion could be identified from genome
sequencing, excellent PCR controls were available: primers were
designed for pathway genes and to amplify across flanking regions,
providing positive PCR products for either the presence or
absence of most pathways, with a few exceptions (File S1).
However, in the cases where the pathways are flanked by long
repetitive elements, primer design to amplify across the pathway
was impractical.
Using the above strategy, there were no cases in which both the
presence and absence reactions were positive, confirming the
robustness of the controls. This analysis also ruled out the
possibility that pathways are inserted in different genomic
contexts, which would be clearly revealed by positive amplification
with the pathway internal primers and negative amplification with
the flanking primers. Strikingly, there is no pattern to the presence
or absence of secondary metabolite genes in the 24 samples studied
(Figure 4). From each ascidian taxonomic group, time point and
location, there are representatives that either contain or lack a
specific pathway. In the cases where pathway products are known,
the presence or absence of a certain pathway relates directly to the
chemicals isolated from the whole ascidian sample.
These results are inconsistent with the two simple hypotheses
proposed. Gene loss alone, although it clearly occurs as
exemplified by a residual methyltransferase in the nkd group,
cannot account for the observed sporadic distribution. Horizontal
acquisition from more distantly related strains also cannot explain
the sporadic occurrence of these pathways, since in that case they
would not be identical, nor would they be likely to always lie in
precisely the same positions. The results are also at odds with the
idea of core and dispensable secondary metabolic genes in
individual bacterial species, since no pathway is universal. Instead,
we propose that this natural gene variation results from horizontal
Symbiont Metagenomes
PLoS ONE | www.plosone.org 5 March 2011 | Volume 6 | Issue 3 | e17897exchange within nearly identical Prochloron strains. At least in
didemnid ascidians in the tropical Pacific, Prochloron strains from
multiple species should be considered as a single population that
can exchange biosynthetic capacity, while nearly all other core
genes are highly conserved.
Colony variation in didemnid ascidians
These differences in pathway types impact the chemistry of
whole ascidian animals found in tropical reef environments. In the
tropical Pacific ascidians of the genus Didemnum molle often form
numerous, adjacent small colonies that are known to fuse and
divide in the course of just a few days [20]. Since we knew from
genome comparison that P. didemni varied in natural product
content, we wished to determine whether even adjacent D. molle
colonies might exhibit this variation. If so, fusion of ascidian hosts
might provide a natural laboratory for recombination and
diversification of ascidian compounds.
D. molle samples 03-002, 03-009 and 03-011 were collected at
adjacent locations in Madang Bay, Papua New Guinea. Although
they appeared very similar to each other, each had a unique
pattern in respect to the five biosynthetic pathways examined,
based on PCR analysis (Figure 4). We sequenced these PCR
products and determined that D. molle samples 03-002 and 03-011
contain tru pathway variants leading to previously unknown
natural products. These products are encoded on similar but not
identical precursor peptides (File S1). We wanted to examine if
this genomic difference directly translated to the chemical content
of the animal colonies. Precise chemical analysis of a single
colony confirmed that 03-002 contained two new cyanobactins of
the rare prenylated group, which often has anticancer activity
(Figure 5). The new cyanobactins, mollamide D (1) and E (2), and
their biosynthetic genes were not found in neighboring ascidian
colonies. These results indicate that three very closely related,
neighboring and possibly fusing ascidian colonies contain the
three examples of evolutionary changes described above,
reinforcing the impact of sporadic diversity on animals in the
environment. In addition to chemical cyanobactin differences,
each of these samples harbors a different reservoir of gene cluster
types. When similar ribosomal peptide pathways are found, the
precursor peptides differ, leading to different products. Together,
these genetic changes result in completely different chemical
compositions.
Discussion
This study demonstrates the power of analyzing biosynthetic
genes from closely related symbionts for the study of pathway
evolution as well as for drug discovery. Two new cyanobactins
were identified in chemical extracts, and three types of pathway
evolution were observed at a very fine scale. The phenomenon of
secondary metabolite variation within and between strains is very
well known. Pathway variation has been extensively studied in
actinomycetes at the genomic level, although in general too many
changes in gene content, conservation, and order are present to
draw the conclusions apparent from this study [35]. Similar
myxobacterial strains have been examined chemically, showing
sporadic presence/absence of pathway types, but it is currently
unclear how this will manifest at the genome level [36]. We
previously described hypervariability within pat and tru precursors,
Figure 4. Sporadic distribution of ascidian-associated secondary metabolic genes across the tropical Pacific. Twenty-four samples
collected over a 5,500 km transect in the tropical Pacific were screened for presence/absence of genes for five biosynthetic pathways. Each circle
represents an individual ascidian sample. The shape inside the circle indicates the species of the Prochloron-harboring ascidian, as shown in the key
above. Colors within the circle represent the presence of individual biosynthetic pathways, which are .99% identical between samples, while black
indicates the absence of a pathway from the sample. S represents samples for which whole genome sequence was obtained.
doi:10.1371/journal.pone.0017897.g004
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peptide sequences has been described in a number of additional
bacterial strains, using bacteria that are not as closely interrelated
as in this study [37]. However, in no case so far is the DNA
sequence identical except in the very small core region of these
peptides. The closely related symbionts, P. didemni, provide a
laboratory in which three levels of precisely observable genomic
change lead to an arsenal of variable natural products.
We speculate that this sporadic pattern might be driven by the
processescontrolling the symbiosisand aneed toevolvenewdefense
strategies for the host. As one example, the patellamides,
trunkamide, and relatives comprise up to 1% of the dry weight of
whole animal-bacterial assemblages, and in some cases they exhibit
lownanomolar toxicity tohumancell lines.Therefore,cyanobactins
arepotent enough and presentin great enoughquantityto influence
the ascidian animal and, potentially, predators or competing
bacteria, although this is a speculative role. Moreover, other
pathways discovered in P.didemni are predicted to synthesize
compounds active against possible competing microbes, such as
the products of pyr and nkd. It is worth re-emphasizing here that the
observed distribution was sporadic – that is, there was no pattern of
co-occurrence, defying simplified attempts at defining roles for these
Figure 5. New prenylated cyanobactins discovered by comparative analysis. A control known compound, trunkamide (3, panel a), was
subjected to high-resolution mass spectrometry analysis. Using tandem mass spectrometry, both one and two isoprene side chains (C5H8,
m/z=68.0626) were eliminated from this molecule. In comparison, two new compounds, mollamide D (1) and mollamide E (2) from sample 03-002,
also exhibited the same pattern (panels b and c). The high-resolution results corresponded both to the predicted masses of the compounds and to
the predicted loss of isoprene.
doi:10.1371/journal.pone.0017897.g005
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unfortunately very common but serve to obscure the reality of
extreme metabolite variation that is actually observed in nature. In
this study, we show that natural products are distributed in a truly
sporadic manner across a population and that it is the major
variable feature in that population. Since the primary role of
bacterial recombination is to repress diversity [38], we propose that
thevariationitself,andnotthe persistenceofindividual molecules,is
the important factor. Instead of producing only a few compounds,
this mechanism allows the population of P. didemni to obtain and
combinatorialize diverse small molecules. In turn, access to these
molecules would help the ascidians and bacteria to face the varying
challenges that are actually encountered in nature. Ascidian fusion
and fission takes place in the course of just a few days [20], allowing
this selection to play out rapidly in response to new challenges.
It has long been anecdotally known that seemingly identical
marine animals contain different natural products, even when they
live adjacently. This has been especially true in the didemnid family
ascidians, where neighboring colonies seem to have different
chemistry. Here, we take a whole genomeapproach and demonstrate
a new process of genetic exchange governing the distribution of
secondary metabolites in the ocean. The sporadic variation
hypothesis explains the observed variation of natural products in
ascidians that harbor Prochloron, and similar types of pathway
variation may impact distribution of other important marine natural
products from ascidians, sponges, and other groups of invertebrates.
Indeed, the Piel group recently described polyketide synthase genes
and a housekeeping gene from bacterial symbionts of sponges [39].
Although the polyketide synthase genes were sometimes present and
sometimes absent, a housekeeping gene was very nearly identical in
samples harboring or missing the polyketide pathway. It thus appears
that pathway variation within otherwise nearly identical symbionts
may be a widespread phenomenon that governs the distribution of
many marine invertebrate natural products. The resulting natural
products play major roles in the environment, in physiological
function, and in drug development. However, this trend is not
universal: for example, it is likely that the bryostatin pathway in
bryozoans does not follow this model [40].
Here, we show that analysis of symbiotic metagenomes provides
precise resolution of pathway presence and evolution and may
therefore be of use in informing synthetic biology. These results
also help to explain the distribution of pharmaceutically important
natural products from marine invertebrates and support continu-
ing exploring a species for new natural compounds. Since colonies
of otherwise identical ascidians can vary in the chemistry
produced, there is potentially an enormous reservoir of undiscov-
ered compounds in these organisms. This chemical diversity can
be explored by simple PCR-based analysis, which can direct
chemical efforts as exemplified by the discovery of mollamides D
and E. Although ribosomal peptides afford a relatively simple
example since the products are directly genetically encoded, as
technologies improve this discovery method will be possible for
other natural product pathway types as well. We provide proof-of-
concept that individual, adjacent animal colonies differ in their
natural product arsenal, implying a new model for discovery of
marine natural products. We also report numerous orphan natural
products clusters that are quite different from characterized
pathways using just a few samples.
Materials and Methods
Ascidian samples
Samples were obtained from reef edges in Palau (P1, 2002), Fiji
(P2, 2006), and the Solomon Islands (P3, 2006). To obtain DNA
for sequencing, freshly collected L. patella was squeezed to release
Prochloron, and DNA was immediately processed as described
previously [15,17]. For P2, the isolated DNA from the squeezed
sample was combined with total DNA isolated from the whole L.
patella sample (1:1 mass ratio). Additional samples for PCR
screening were obtained from Palau, Papua New Guinea,
Solomon Islands, and Fiji in years 2002, 2003, 2005, 2006 and
2007. Habitats included channels, harbors, seagrass beds, reef tops
and edges, walls, and seamounts, while organisms included several
species in the genera Lissoclinum, Didemnum, and Diplosoma. Fosmid
libraries with an average insert size of 40,000 bp were generated
from samples P1 and P2 as previously described [15,17].
Collection locations are defined in File S1. Samples were obtained
with appropriate permits and agreements in place.
DNA sequencing
Whole-genome sequence data for P1 were generated using
Sanger sequencing as described previously [6]. 454 GS20
pyrosequencing was performed on sample P1 to increase coverage.
Since DNA isolations from the squeezed samples yield a small
fraction of non-Prochloron or eukaryotic host DNA (together ,5%),
a separation of Prochloron sequence reads was achieved using the
Glimmer gene finding software [41]. All sequence reads from the
P1 sample, including 107,589 Sanger reads and 1,285,077 454
reads, were assembled using Celera Assembler and a large number
of the remaining sequence gaps closed through primer walking
and PCR closure techniques. Samples P2 and P3 were sequenced
using the 454 GS FLX Titanium series with a total number of
2,837,355 and 387,519 sequence reads, respectively. To separate
P. didemni sequence contigs in the P2 and P3 samples from
eukaryotic or other bacterial sequence contigs, the PhymmBL
metagenomic classification tool was applied, which uses Interpo-
lated Markov Models [42]. Since both samples were mainly
composed of P. didemni genomic DNA, it was assumed that larger
contigs would be almost entirely composed of P. didemni sequence
reads. Consistently, PhymmBL classified these contigs as belonging
to the phylum Cyanobacteria. To check whether PhymmBL could
be optimized for the detection of P. didemni sequences, a new
Interpolated Markov Model based on all contigs from the P2
sample larger than 10 kbp was built. Using this optimized model,
no significant improvement of contig separation could be
achieved. While contigs previously identified as P. didemni scored
slightly better with the new model, it did not assign contigs that
were previously not assigned to cyanobacteria to P. didemni.I n
addition, Sanger fosmid end sequences from each constructed
library were obtained (5696 well plates from P1 and 7696 well
plates from P2) with an average read length of 800 bp.
Genome analysis
The P1 draft genome now consists of 39 scaffolds, i.e. ordered
contigs that are connected through paired-end sequence reads
spanning physical gaps between the contigs, with a total sequence
length of ,6,035,098 bp. The PhymmBL metagenomic sequence
classification tool assigned 3,261 contigs and 1,964 contigs of the
P2 and P3 samples, respectively, to the phylum Cyanobacteria,
which together add up to a total size of 7,519,338 bp (31.5% of the
total P2 metagenome) and 5,855,009 bp (82.0% of the total P3
metagenome). These contigs were considered P. didemni sequence
and used for all following analyses. The fragmentation of the
Prochloron draft genomes does not result from an insufficient
sequencing coverage as revealed by more than 12x coverage in
contigs $1 kb.
Overall genome comparison between P1, P2 and P3 showed
large regions of synteny and average nucleotide identity of .97%.
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fosmid mapping from one genome onto the others, comparisons of
large contigs (.50 kb) on the DNA and protein sequence level,
and the identification of core gene sets shared between the three
genomes. Despite this high degree of conservation, different
secondary metabolic gene clusters were identified in all three
genomes. In order to understand the genetic basis behind the
variation in the secondary metabolome content, biosynthetic gene
clusters including the surrounding genomic contexts were
compared in detail.
Demonstration of synteny in genomes
Numerous methods were used to show that the genomes were
largely identical and syntenic. Although all three genome datasets
are highly fragmented, contigs of a combined length of ,500 kbp
from all three genomes (,8%) could be mapped and compared
(Figure 2 and File S1). For example, P1 contig ASM-2318 is
241,607 bp in length. When comparing it to the P2 assembly, 22
contigs of different sizes mapped readily to it with no apparent
synteny breaks except in a secondary metabolite gene cluster, pat1.
When the same contig was compared to the more fragmented P3
assembly, 40 contigs mapped with only three apparent synteny
breaks. Among those, two were related to the secondary metabolic
gene clusters (pat1 and nkd) while the third one appears to result
from a genome rearrangement event or misassembly in P3. It
should be emphasized that we can only be certain of synteny
within the contiguous P2 and P3 regions that map to P1, while
each contig end is a potential synteny break, since the contig order
was not determined experimentally. To test whether the P2 contigs
are arranged in the same order as in P1, we mapped the end
sequences of 29 P2 fosmids with .99% DNA sequence identity to
P1 contig ASM-2318. Indeed, the mapped paired-end sequence
reads confirmed that the organization of P2 was identical to P1
over ASM-2318 (File S1). Similarly, P1 contig ASM-2352
(193,832 bp) was mapped to 21 contigs of P2 (no apparent major
synteny breaks), and 29 contigs of P3 (only one synteny break of a
region present elsewhere in P1 and P2, which could be due to
genome rearrangement or misassembly) (File S1). Further, this
assumption is supported by dot plots of nucmer comparisons of all
contigs .5 kbp (P1: 83 contigs, P2: 342 contigs, P3: 347 contigs),
which show no indication of within-contig synteny breaks (File S1).
Precise locations could be identified where clusters involved in
secondary metabolism were integrated into the P. didemni genomes;
when a pathway was missing in a strain, the exact site of
integration could be found because of highly conserved flanking
genes.
Identification of secondary metabolic genes in P1, P2,
and P3
To identify secondary metabolic gene clusters in P1, a database
was constructed by compiling protein sequences from GenBank of
secondary metabolism biosynthetic genes of all types of interest
from different organisms. These included nonribosomal peptide
synthetases, polyketide synthases, cyanobactin synthetases together
with all the auxiliary modifying enzymes including methyltrans-
ferases, oxidases, heterocyclases, and others. When this database
was compared to the P1 assembly using tBLASTn [43], a few
contigs were identified as hits and were analyzed in detail. Two
polyketide synthase gene clusters, one nonribosomal peptide gene
cluster, two cyanobactin gene clusters and two ribosomal peptide
gene clusters were identified using this method. All identified hits
were confirmed using the gene finding tool Glimmer and the gene
annotation tool Manatee from The Institute For Genomic
Research (TIGR) [41]. In addition, a terpene gene cluster was
identified using Manatee.
To compare this set of gene clusters to the biosynthetic pool of
P2 and P3, a similar but more complex pipeline was developed
(File S1). First, the assembled whole metagenomic data sets from
P2 and P3 were compared against the same secondary metabolite
biosynthetic gene set (using tBLASTn) to identify matching contigs
and unassembled sequence reads. These matching sequences were
confirmed to originate from cyanobacterial species based on the
taxonomic classification of all contigs and unassembled reads using
the PhymmBL tool [42]. Matching sequences from cyanobacteria
were then compared to paired-end sequences from fosmid libraries
generated from DNA isolated from sample P2 and to assembled
contigs from P1 to assure that they originated from P. didemni and
not from any other cyanobacteria in the metagenome. For
example, fosmid clones containing a new gene cluster on one end
and a sequence with 97% percent identical to a P1 contig on the
other end clearly originate in Prochloron. The newly identified
secondary metabolite gene cluster-containing contigs that had no
matches among fosmid sequences were compared to the longer P1
contigs using NUCmer and Artemis Comparison Tool (ACT)
[44,45]. In most cases, newly identified secondary metabolite gene
clusters represented the only observed differences between the
samples P2 or P3 and P1 in otherwise virtually identical (.97%
DNA sequence identity) backgrounds. Using these methods, six
additional gene clusters were identified in P2 and P3, encoding
nonribosomal peptides, cyanobactins and ribosomal peptides.
Detailed analysis of specific secondary metabolic
genomic regions
A reverse pipeline to the one described above was developed
(File S1). In this pipeline, large secondary metabolic contigs from
P1 were used as a query and compared to the P2 and P3
metagenomic data sets. Identified hits were used for a pairwise
NUCmer comparison against the original P1 contig. For a more
detailed comparison method, identified contigs were concatenated
manually to form a pseudomolecule, guided by information from
NUCmer comparisons and paired-end fosmid mappings. ACT
was used to visualize BLAST comparisons of the pseudocontig to
the original P1 contig. This later comparison allowed the
observation of differences as small as 1 kb between the compared
contigs.
PCR screening
Primer pairs were designed based on the identified secondary
metabolite biosynthetic gene clusters in P1, P2 and P3. When gene
clusters were present in one genome and absent in another (pyr,
nkd), primers were designed to detect both genotypes (File S1).
When gene clusters were present in all three genomes (gaz, pat and
tru), primers were designed to only detect the presence of a
pathway. All PCR products indicative of the presence of pat and tru
were sequenced and verified. Reactions were optimized for each
primer set and employed negative (sterile water) and positive
controls.
GenBank
All of the described data has been deposited in GenBank,
accession numbers HQ407366-HQ407375.
New cyanobactins
Ascidian samples were extracted with methanol and analyzed
using high pressure liquid chromatography-electrospray-time of
flight mass spectrometry (HPLC-ESI-TOF). Sample 03-002 was
Symbiont Metagenomes
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cyanobactins. Sequence results from sample 03-002 showed that
this sample should contain cyanobactins with sequences TTVTAC
(mollamide D, 1) and TLSPFC (mollamide E, 2) (File S1). Sample
03-002 is a D. molle colony that is of insufficient size to perform
nuclear magnetic resonance experiments. Therefore, we developed
mass spectrometry methods that exploited the property of
prenylation to definitively characterize the planar structures of the
compounds, using the control compound trunkamide (3).
The predicted 1 and 2 were dominant in the HPLC traces of
both TOF and FT mass spectrometry experiments (File S1). FTMS:
1: m/z =763.44345; predicted 763.44223 for C38H62N6O8S
(D=1.6 ppm). 2: m/z =699.35469; predicted 699.35342 for
C35H50N6O7S( D=1.8 ppm). (3): m/z =838.45245; predicted
838.45312 for C43H63N7O8S( D=20.8 ppm).
Tandem mass spectrometry (ms
2) of the known compound 3 using
infrared multiphoton dissociation (IRMPD) led cleanly to loss of both
one and two isoprene units without significant further fragmentation,
providing a predictable pattern. Importantly, isoprene was lost with
high resolution, providing extremely strong evidence of composition of
matter. In tandem with sequencing data, this level of evidence is very
high and similar to what is routinely reported in proteomics-based
analyses. However, these data do not differentiate between the possible
sites for placement of isoprene on 2.I R M P D :1:- 1xi s o p r e n e :m/z
=695.37764; predicted 695.37963 for C33H54N6O8S( D=22.8 ppm);
-2 x isoprene: m/z =627.31593; predicted 627.31703 for
C28H46N6O8S( D=21.7 ppm); -3 x isoprene m/z =559.25347;
predicted 559.25443 for C23H38N6O8S( D=21.8 ppm). 2:- 1x
isoprene: m/z =631.29075; predicted 631.29082 for C30H42N6O7S
(D=20.01 ppm). 3 (standard): -1 x isoprene: m/z =770.39055;
predicted 770.39053 for C38H5N7O8S( D=20.03 ppm); -2 x isoprene:
m/z =702.32788; predicted 702.32793 for C33H47N7O8S
(D=20.07 ppm).
Supporting Information
File S1 Supporting figures and tables. This file contains
supporting figures and tables describing the samples used in this
study, genome statistics, bioinformatics pipelines employed,
genome synteny analyses, biosynthetic pathway analyses and
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